Fig. 3

Changes in potassium in Mid-Sweden Cohort during 60 days after initiating potassium binder treatment. The scatter plot shows individual potassium measurements over time in patients treated with first- or second-generation potassium binders. The solid lines represent predicted potassium levels derived from a mixed-effects model adjusted for age, sex, heart failure, hypertension, chronic kidney disease, diabetes, use of RASi and MRA, and baseline potassium levels. Prediction mean with error bars reflecting 95% confidence intervals are presented for the median patient at index and 15-, 30-, 45-, and 60-days post-index)